Claritev adds Jennifer Main to its board of directors

Claritev Corporation (NYSE: CTEV) has appointed Jennifer Main to its board of directors, effective Oct. 15, 2026, filling a newly created board seat, according to a press release from the company.

Main currently serves as Chief Financial Officer of RealMDai (dba Certuma) and Overture Life, positions she has held since March 2026. Before that, she served as Chief Financial Officer and Chief Operating Officer of Amalgam Rx from 2021 to 2026.

Main previously held several roles at the Centers for Medicare & Medicaid Services (CMS), most recently as Chief Operating Officer from 2018 to 2021, where she oversaw operations across Medicare, Medicaid, and federal health insurance marketplace programs. She also served as Chief Financial Officer for the Troubled Assets Relief Program (TARP) at the U.S. Department of Treasury, where she managed financial services for the $700 billion program created in response to the 2008 financial crisis.

Main holds a master's degree in public policy from Harvard University and a bachelor's degree in history from Cornell University.

"Jenni brings a valuable combination of financial leadership, healthcare experience, and public sector perspective," said Travis Dalton, President and CEO of Claritev.

You May Also Be Interested In

• Claritev Appoints Jennifer Main to its Board of Directors
• Freedom Gold extends share offering, plans unit placement and debt settlement
• Sinda makes board and leadership changes after NYSE IPO